$6.19
-0.04-0.64%
At close: -
$6.36
0.172.75%
After Hours: Dec 23, 4:00 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Acrivon Therapeutics in recent months.
Browse guidance and forecast on all stocks.